Comparably to malignant melanoma, a heterogeneous amount of PD-1, Tim-3, CTLA-4, LAG-3, and BTLA were expressed on intratumoral CD8+ T cells from 32 patients with NSCLC. This evidence concerns the gene CD8A and melanoma.